Xeriant, Inc.: Form 10-Q for the period ended Dec 31, 2024
Filed with the SEC on Feb 14, 2025 and accepted by EDGAR at Feb 14, 2025, 14:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2024-10-01 to 2024-12-31 | $15 | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2024-07-01 to 2024-12-31 | $26.6k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-10-01 to 2024-12-31 | −$335.6k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-07-01 to 2024-12-31 | −$694.4k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-10-01 to 2024-12-31 | $51.4k | us-gaap:InterestExpense |
| Interest expense | 6 months2024-07-01 to 2024-12-31 | $113.0k | us-gaap:InterestExpense |
| Income tax | 3 months2024-10-01 to 2024-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-07-01 to 2024-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-10-01 to 2024-12-31 | −$410.1k | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-07-01 to 2024-12-31 | −$774.9k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-10-01 to 2024-12-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-07-01 to 2024-12-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2024-10-01 to 2024-12-31 | 596,196,491 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-07-01 to 2024-12-31 | 571,876,754 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-07-01 to 2024-12-31 | −$750.9k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | At period end2024-12-31 | $268.6k | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $276.6k | us-gaap:Assets |
| Total liabilities | At period end2024-12-31 | $9.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-12-31 | −$5.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-25-001010. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.